Agilex has offered our clients small molecule solutions that lead to their success. Agilex Biolabs is celebrating its 29th year...
Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decades before antibody drugs were d...
We took some time to sit down and talk with Cameron so you could get to know him a bit better... My name is Cameron Smith. I'm...
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...
Small and large molecule drug development often necessitates distinct analytical methodologies. Agilex has extensive experience de...
Agilex has extensive experience developing and validating like-binding assays for specific immune-oncology therapeutics. From a...
How do Australia's streamlined regulatory process and global tax incentive apply to your toxicology studies? There are many ben...
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
by Kurt Sales The rise of Cell and Gene Therapy products is increasingly becoming more prevalent. At Agilex we are seeing more...
The Role of Peripheral Blood Mononuclear Cells (PBMCs) in Drug Discovery and Clinical Trials. By Dr. Kurt Sales, CSO In the...
By Dr. Kurt Sales, CSO Oligonucleotides, including small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have gai...
There’s a great opportunity for Australian SME’s to take advantage of a well-deserved subsidy! Agilex Biolabs is thrilled t...
By Dr. Kurt Sales, CSO In the high-stakes world of drug development, biotech companies face unique challenges at every stage -...
By Dr. Kurt Sales, CSO Liquid chromatography-mass spectrometry (LCMS) has become an indispensable tool for the pharmaceutical a...
By Dr. Kurt Sales, CSO Preclinical toxicology studies are an essential part of the drug development process as they provide ins...
By Dr. Kurt Sales, CSO Biomarkers are playing an increasingly important role in clinical studies where they can provide essenti...
by Dr. Kurt Sales, Chief Scientific Officer Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been the preferred an...
An exclusive delegation coming from Australia - where leading drug development experts will converge. The Agilex team would lik...
Flow cytometry has become a powerful tool in the bioanalytical arsenal. In an era where pharmaceuticals are becoming more targe...
